Rifampicin
Simon, F.; Bohand, X.
Medecine Tropicale Revue du Corps de Sante Colonial 58(3): 229-230
1998
ISSN/ISBN: 0025-682X PMID: 10088095 Document Number: 490590
Document emailed within 1 workday
Related Documents
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149Saltoglu, N.; Tasova, Y.; Inal, A.S.; Seki, T.; Aksu, H.S. 2002: Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis Saudi Medical Journal 23(8): 921-924
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Reimers, D. 1971: Malformations caused by rifampicin? 2 cases of normal fetal development after rifampicin treatment in early pregnancy Münchener Medizinische Wochenschrift 113(50): 1690-1691
Acocella, G.; Segre, G. 1974: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations Acta Pharmaceutica Suecica 11(6): 657-658
Tamura, M.; Yamazaki, A.; Tamura, T.; Takano, S.; Yamazaki, M. 1973: The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media Kekkaku: 48(6): 247-253
Wehrlin, N. 1972: Rifampicin Revue de l'Infirmiere 22(5): 507-510
Cordero, L.; Echániz, A.; Núñez, M.; Pereira, S.; Romero, E. 1999: Thrombocytopenia associated with rifampicin Anales de Medicina Interna 16(5): 269
Fafrowicz, B. 1971: Rifampicin and its clinical use Wiadomosci Lekarskie 24(3): 233-238
Naik, R.P.; Balachandran, C.; Ramnarayan, K. 1985: Fixed eruption due to rifampicin Indian Journal of Leprosy 57(3): 648-650
Chouraqui, J.P. 1986: Rifampicin, vitamin K and osteomalacia Archives Francaises de Pediatrie 43(4): 292
Austerhoff, A.; Knop, P.; Brennecke, F.G.; Kindler, U.; Scholten, T.; Knieriem, H.J. 1973: Liver toxicity of rifampicin Die Medizinische Welt 24(17): 695-696
Nagai, S.; Izumi, T. 1974: Immunosuppressive effects of rifampicin (RFP) Kekkaku: 49(11): 375-382
Zyczyński, T. 1972: Rifampicin: a new antitubercular agent Wiadomosci Lekarskie 25(3): 251-254
Favez, G. 1970: A new antitubercular agent: rifampicin Schweizerische Rundschau für Medizin Praxis 59(8): 296-297
Shorin, V.A.; Kunrat, L.A. 1974: Rifampicin pharmacokinetics in rabbits Antibiotiki 19(11): 978-981
Unterdorfer, H.; Battista, H.J. 1981: Rifampicin poisoning with fatal course Beitrage Zur Gerichtlichen Medizin 39: 393-396
Purohit, S.D.; Gupta, P.R.; Sarkar, S.K.; Sisodia, R.S.; Garg, A.K. 1982: Intracavitary instillation of rifampicin Journal of the Association of Physicians of India 30(7): 480